Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Performance of Streck cfDNA Blood Collection Tubes for Liquid Biopsy Testing.

Medina Diaz I, Nocon A, Mehnert DH, Fredebohm J, Diehl F, Holtrup F.

PLoS One. 2016 Nov 10;11(11):e0166354. doi: 10.1371/journal.pone.0166354. eCollection 2016.

2.

Detection and Quantification of KIT Mutations in ctDNA by Plasma Safe-SeqS.

Fredebohm J, Mehnert DH, Löber AK, Holtrup F, van Rahden V, Angenendt P, Diehl F.

Adv Exp Med Biol. 2016;924:187-189.

PMID:
27753042
3.

In vivo activity and pharmacokinetics of nemorosone on pancreatic cancer xenografts.

Wolf RJ, Hilger RA, Hoheisel JD, Werner J, Holtrup F.

PLoS One. 2013 Sep 5;8(9):e74555. doi: 10.1371/journal.pone.0074555. eCollection 2013.

4.

Comparison of the cytotoxic effects of enantiopure PPAPs, including nemorosone and clusianone.

Simpkins NS, Holtrup F, Rodeschini V, Taylor JD, Wolf R.

Bioorg Med Chem Lett. 2012 Oct 1;22(19):6144-7. doi: 10.1016/j.bmcl.2012.08.023. Epub 2012 Aug 11.

PMID:
22944119
5.

Replication and virus-induced transcriptome of HAdV-5 in normal host cells versus cancer cells--differences of relevance for adenoviral oncolysis.

Dorer DE, Holtrup F, Fellenberg K, Kaufmann JK, Engelhardt S, Hoheisel JD, Nettelbeck DM.

PLoS One. 2011;6(11):e27934. doi: 10.1371/journal.pone.0027934. Epub 2011 Nov 30.

6.

Microarray analysis of nemorosone-induced cytotoxic effects on pancreatic cancer cells reveals activation of the unfolded protein response (UPR).

Holtrup F, Bauer A, Fellenberg K, Hilger RA, Wink M, Hoheisel JD.

Br J Pharmacol. 2011 Mar;162(5):1045-59. doi: 10.1111/j.1476-5381.2010.01125.x.

7.

Terrylenimides: New NIR Fluorescent Dyes.

Holtrup FO, R J Müller G, Quante H, De Feyter S, De Schryver FC, Müllen K.

Chemistry. 1997 Feb;3(2):219-25. doi: 10.1002/chem.19970030209.

PMID:
24022951

Supplemental Content

Loading ...
Support Center